Moleculin Biotech, Inc. (MBRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -6.11M | -5.37M | -7.22M | -5.58M | -4.56M | -5.08M | -6.11M | -5.95M | -6.72M | -5.41M | -7.55M | -5.13M | -6.02M | -7.26M | -7.58M | -8M | -4.8M | -4.26M | -4.29M | -6.78M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -33.9% | -5.57% | -18.16% | 6.17% | 32.05% | 5.99% | 19.04% | -16.06% | -11.63% | 25.48% | 0.34% | 35.93% | -25.22% | -70.41% | -76.7% | -17.99% | -32.59% | -36.3% | 20.18% | -37.46% |
| Net Income | -12.85M | 15.55M | -25.4M | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M |
| Depreciation & Amortization | 8K | 9K | 21K | 28K | 31K | 31K | 32K | 31K | 32K | 35K | 31K | 31K | 30K | 32K | 32K | 34K | 32K | 34K | 42K | 44K |
| Stock-Based Compensation | 380K | 459K | 0 | 417K | 485K | 427K | 353K | 453K | 493K | 479K | 493K | 513K | 499K | 535K | 699K | 514K | 527K | 556K | 979K | 433K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -59K | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.17M |
| Other Non-Cash Items | 5.21M | -23.27M | 19.85M | 1.95M | 650K | -4.71M | 3.57M | -1.7M | -1.35M | 1.19M | 1K | -42K | 843K | -155K | -25K | 351K | -70K | -2.31M | -1.69M | -4K |
| Working Capital Changes | 1.13M | 1.88M | -1.7M | -335K | 706K | 1.05M | 528K | -418K | -925K | 3.21M | -2.47M | 348K | 526K | -898K | 328K | -2.12M | 1.57M | 283K | 756K | -1.84M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.07M | 1.29M | -1.48M | 850K | 676K | -520K | -283K | 729K | -394K | 490K | -2.13M | 2.2M | -156K | -1.47M | 0 | 0 | 860K | -26K | -115K | -423K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13K | 0 | -81K | -28K | -15K | 0 | 0 | 0 | -61K | -6K | -19K | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13K | 0 | -81K | -28K | -15K | 0 | 0 | 0 | -61K | -6K | -19K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 7.61M | 7.49M | 6.38M | 5.42M | 8M | 1K | 4.66M | -25K | 0 | 4.46M | -4K | 49K | 141K | 0 | -11K | -12K | 0 | 0 | -24K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 7.61M | 7.5M | 6.38M | 5.42M | 8M | 1K | 4.66M | -25 | 0 | 3.96M | -4K | 70K | 141K | 0 | -11K | -12K | 0 | -1K | 0 | 0 |
| Dividends Paid | -1.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25 | 0 | 0 | -4K | 0 | 0 | 0 | -11K | -12K | 0 | 0 | 0 | 0 |
| Other Financing | 1.76M | -8K | 0 | 6K | 4K | 0 | -1K | -24.98K | 0 | 510K | 0 | -21K | 0 | 0 | 0 | 0 | 0 | 1K | -24K | 0 |
| Net Change in Cash | 1.44M | 2.17M | -854K | -159K | 3.44M | -5.13M | -1.44M | -5.98M | -6.73M | -1.03M | -7.59M | -5.09M | -5.88M | -7.25M | -7.61M | -8.11M | -4.8M | -4.28M | -4.33M | -6.79M |
| Free Cash Flow | -6.11M | -5.37M | -7.22M | -5.58M | -4.56M | -5.08M | -6.11M | -5.96M | -6.72M | -5.49M | -7.58M | -5.14M | -6.02M | -7.26M | -7.58M | -8.06M | -4.81M | -4.28M | -4.29M | -6.78M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -33.9% | -5.57% | -18.16% | 6.37% | 32.05% | 7.38% | 19.34% | -15.97% | -11.63% | 24.37% | -0.03% | 36.23% | -25.07% | -69.65% | -76.7% | -18.89% | -32.75% | -36.21% | 24.93% | -36.96% |
| FCF per Share | -0.15 | -0.45 | -4.84 | -8.99 | -1221.30 | -37.61 | -41.15 | -58.61 | -68.09 | -68.49 | -95.34 | -64.94 | -78.48 | -95.05 | -99.25 | -105.77 | -63.13 | -56.12 | -56.28 | -89.38 |
| FCF Conversion (FCF/Net Income) | 0.48x | -0.35x | 0.28x | 0.73x | 0.71x | 2.70x | 0.58x | 1.38x | 1.35x | 0.53x | 1.35x | 0.86x | 0.76x | 1.07x | 0.88x | 1.18x | 0.70x | 1.51x | 0.98x | 1.60x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109K | 0 | 4K | 7K |